Dr. Chad Max Bingham, MD

Dr. Bingham practices at Eye Care Physicians & Surgeons, Inc. in Salem, Oregon.

Dr. Bingham's NPI, 1255436168, was assigned on September 14, 2006. Dr. Bingham graduated from Geisel School Of Medicine At Dartmouth in 2006. Dr. Bingham's West Virginia license number on file is 24353.

Dr. Bingham's primary practice is Eye Care Physicians & Surgeons, Inc., at 1285 Liberty SE St, Salem, OR 97302 in Marion County. The practice phone is (503) 585-2022.

Dr. Bingham's primary practice is Eye Care Physicians & Surgeons, Inc. in Salem, Oregon. Dr. Bingham is also affiliated with Salem Hospital. Dmand AI also links Dr. Bingham to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bingham practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Bingham's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Bingham is board certified in fellow by the American Academy of Ophthalmology. Dmand AI has Dr. Bingham's licenses on file in 2 states: West Virginia and Oregon.

Dmand AI lists dry eye and eyelid inflammation among the conditions Dr. Bingham treats.

CMS data shows 970 Medicare services from Dr. Bingham across 16 procedure codes in 2024, for 568 Medicare patients. Medicare paid $132,230 for them.

CMS counts 568 Medicare patients who saw Dr. Bingham in 2024. The largest group is 65 to 74, with 242 patients. 63% of them have high blood pressure, and 63% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bingham's median patient age at 70, with 63% women.

In 2024, Dr. Bingham wrote 1,400 Medicare Part D claims for 718 patients. 92% of them were for generic drugs. CMS names the drug for 1,313 of them, across 9 drugs with 11 or more claims each, at $13,293 in total drug cost. In 2023, CMS named 1,227 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Bingham for performance year 2024, reported as part of a group. CMS counts 60 procedures of skin biopsy by Dr. Bingham, more than 70% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Bingham in 2005. The most frequent topics are Orbit, Graves Ophthalmopathy and Lacrimal Apparatus. Dr. Bingham has published most often in Ophthalmic Plast Reconstr Surg. Dr. Bingham's most frequent co-authors are Jennifer A. Sivak-Callcott, MD, Matheson Adams Harris, MD and Alexandra Castro.

CMS Open Payments shows 3 general payments to Dr. Bingham from 2 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $29.

Dmand AI lists 1 award for Dr. Bingham, most recently CMS Stage 1 EHR in 2013.

Dr. Bingham graduated from Geisel School Of Medicine At Dartmouth in 2006.

Dr. Bingham is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.